
Keywords: CAFs, cancer associated fibroblasts; CTLA4, anti-cytotoxic T-lymphocyte-associated protein 4; CSF-1, colony stimulating factor-1; ECM, extracellular matrix; FAP, fibroblast activation protein-α; HEVs, high endothelial venules; IDO, indoleamine-pyrrole 2,3